How should a child with suspected acetaminophen (paracetamol) overdose be evaluated and treated, including toxicity dose thresholds, use of activated charcoal, N‑acetylcysteine regimen, and monitoring?

Paracetamol Toxicity in Children: Evaluation and Management

Toxic Dose Thresholds

In children, hepatotoxicity risk begins at single acute ingestions exceeding 150 mg/kg or 7.5 g (whichever is lower), though severe toxicity typically requires doses above 200 mg/kg. 1

• For repeated supratherapeutic ingestions (RSI), treat with N-acetylcysteine if the child received ≥200 mg/kg within any 24-hour period, or ≥150 mg/kg/day for ≥48 hours 1
• Even therapeutic dosing (75–90 mg/kg/day) during febrile illness for >24 hours can cause hepatotoxicity in susceptible children; check liver enzymes if this threshold is exceeded 2
• A case report documented fulminant hepatic failure in a 5-year-old after only 90 mg/kg/day for 3 consecutive days, emphasizing individual susceptibility 3

Initial Assessment and Risk Stratification

Obtain a serum paracetamol concentration at least 4 hours post-ingestion and plot it on the Rumack-Matthew nomogram to guide treatment decisions for single acute ingestions. 4, 1

Critical timing considerations:

• If the child presents <4 hours post-ingestion: the level may not yet reflect peak absorption; obtain a second level at 4 hours to determine treatment need 5
• If 4–24 hours post-ingestion with known timing: use the nomogram immediately 1
• If >24 hours post-ingestion: the nomogram does NOT apply—base treatment on any detectable paracetamol level, elevated transaminases (AST/ALT >50 IU/L), or clinical suspicion 4, 1
• If timing unknown: start NAC immediately and obtain levels to guide continuation 4, 6

Laboratory workup:

• Baseline: AST, ALT, bilirubin, INR/PT, creatinine, BUN, glucose, electrolytes 5
• Repeat daily if paracetamol level is in the toxic range 5
• Consider co-ingestions in adolescents; obtain comprehensive toxicology screen 7

Activated Charcoal Administration

Give activated charcoal (1 g/kg orally) if the child presents within 4 hours of ingestion, administered just prior to starting NAC. 4, 1

• Charcoal is most effective within 1–2 hours but retains benefit up to 4 hours post-ingestion 1
• In massive overdoses (≥40 g or ≥500 mg/kg), charcoal given within 4 hours significantly reduces paracetamol absorption: median paracetamol ratio 1.4 versus 2.2 without charcoal (p<0.0001), and lowers hepatotoxicity risk (adjusted OR 0.20) 8
• Do NOT delay NAC while administering charcoal—give charcoal first, then immediately start NAC 4, 1
• If the child has altered mental status or cannot protect their airway, do NOT give charcoal 1

N-Acetylcysteine (NAC) Treatment Regimen

Start NAC immediately if paracetamol concentration plots at or above the "possible toxicity" line on the Rumack-Matthew nomogram, or if ≤24 hours have elapsed and the ingestion meets toxic dose criteria, even before laboratory confirmation. 4, 1, 5

Timing is critical for outcomes:

• Treatment within 8 hours: only 2.9% develop severe hepatotoxicity; no deaths in pediatric cohorts 4, 1
• Treatment within 10 hours: 6.1% severe hepatotoxicity 4, 1
• Treatment 10–24 hours: 26.4% severe hepatotoxicity 4, 1
• Treatment >10 hours: 53% severe hepatotoxicity with 5% mortality in high-risk patients 1
• All 11 deaths in the landmark Smilkstein pediatric cohort occurred in children treated >10 hours post-ingestion 1

NAC dosing options:

Intravenous regimen (21-hour protocol): 4, 6

• Loading dose: 150 mg/kg in 5% dextrose or 0.45% saline over 15 minutes
• Second dose: 50 mg/kg over 4 hours
• Third dose: 100 mg/kg over 16 hours
• Total dose: 300 mg/kg over 21 hours

Oral regimen (72-hour protocol): 4, 5

• Loading dose: 140 mg/kg diluted to 5% solution in diet cola or soft drink
• Maintenance: 70 mg/kg every 4 hours for 17 additional doses (total 18 doses)
• If the child vomits within 1 hour of any dose, repeat that dose 5
• For persistent vomiting, consider duodenal intubation or switch to IV route 5

Special pediatric considerations:

• Reduce total fluid volume in children <40 kg or those requiring fluid restriction to prevent hyponatremia and cerebral edema 6
• Both IV and oral regimens are equally effective; IV is preferred if vomiting, altered mental status, or massive overdose 2
• The oral regimen may be superior when treatment is delayed >10 hours 4

Indications to Start NAC Regardless of Nomogram

Administer NAC immediately in these scenarios, even without confirmatory levels or nomogram plotting: 4, 1

• Any evidence of hepatotoxicity (AST/ALT >50 IU/L, elevated bilirubin, or coagulopathy)
• Acute liver failure with suspected paracetamol ingestion, even without clear history
• Repeated supratherapeutic ingestions meeting dose criteria (≥200 mg/kg/24h or ≥150 mg/kg/day for ≥48h)
• Extended-release formulations (absorption may be prolonged; obtain serial levels at 4h and 8–12h post-ingestion)
• Unknown time of ingestion with any detectable paracetamol level
• Presentation >24 hours post-ingestion with detectable paracetamol or elevated transaminases
• High-risk populations: chronic malnutrition, prolonged fasting, concurrent enzyme-inducing medications (phenytoin, carbamazepine, rifampin) 4, 1

Monitoring and Duration of NAC Therapy

Continue NAC for the full 21-hour IV protocol or 72-hour oral protocol unless specific low-risk criteria are met. 4, 1

Criteria to discontinue NAC early (use ALL criteria):

• Paracetamol level undetectable
• AST and ALT remain normal (<50 IU/L)
• INR normal
• Patient asymptomatic
• Presentation was <24 hours post-ingestion with reliable history 4

Extend NAC beyond standard protocol if: 4, 1

• Transaminases rising or remain elevated (continue until declining and INR normalizing)
• Detectable paracetamol level at end of protocol
• Delayed presentation (>24 hours)
• Extended-release formulation
• Massive overdose (≥40 g or ≥500 mg/kg)
• Acute liver failure (continue until transplant or recovery)

Outcomes and Prognosis

With early NAC treatment (<8 hours), pediatric outcomes are excellent: no deaths and <3% severe hepatotoxicity in large cohorts. 4, 1

Risk stratification by transaminase elevation:

• AST 50–1,000 IU/L: ~15% progress to hepatotoxicity, ~2% mortality 1
• AST >1,000 IU/L: defines severe hepatotoxicity; ~14% mortality without transplant 1
• Peak transaminases typically occur at 72–96 hours; most children recover to normal by 7–8 days 7

NAC efficacy in established liver failure:

• Reduces mortality from 80% to 52% even when started after hepatotoxicity develops 4, 1
• Improves 21-day survival from 25% to 48% 4
• Decreases progression to grade III–IV encephalopathy from 75% to 51% 4

Critical Pitfalls to Avoid

• Never delay NAC while awaiting laboratory confirmation if history suggests significant ingestion 4, 1
• Do not use the nomogram for repeated supratherapeutic ingestions, extended-release formulations, or presentations >24 hours 4, 1
• Low or undetectable paracetamol levels do NOT exclude toxicity if ingestion was remote or occurred over multiple days 4
• Therapeutic dosing can cause toxicity in febrile children receiving >75 mg/kg/day for >24 hours; maintain high index of suspicion 2
• Adolescent ingestions require psychiatric evaluation for intentional self-harm 7
• Refer immediately to transplant hepatology if AST >1,000 IU/L, INR >2.0, or any encephalopathy develops 1

Adverse Effects of NAC

• Cutaneous rash: <5% of pediatric patients 4
• Transient bronchospasm: 1–2% (more common with IV bolus; slow infusion if occurs) 4
• Anaphylactoid reactions: rare; temporarily stop infusion, treat with antihistamines, then cautiously restart at slower rate 6
• NAC is remarkably safe; benefits far outweigh risks even in uncertain cases 9